Cetuximab for Unresectable Cutaneous Squamous Cell Carcinoma - A National Retrospective Study

Clinical trial NCT03325738 · COMPLETED

Trial details

NCT number: NCT03325738
Sponsor: Centre Antoine Lacassagne
Status: COMPLETED
Study type: OBSERVATIONAL

Squamous Cell Cutaneous Carcinoma of the Skin

Start date: 2017-06-30
Primary completion: 2017-06-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.